Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Publication
, Journal Article
Published in: New England Journal of Medicine
September 7, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
New England Journal of Medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
September 7, 2023
Volume
389
Issue
10
Start / End Page
959 / 962
Publisher
Massachusetts Medical Society
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. (2023). New England Journal of Medicine, 389(10), 959–962. https://doi.org/10.1056/nejmc2308757
“Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.” New England Journal of Medicine 389, no. 10 (September 7, 2023): 959–62. https://doi.org/10.1056/nejmc2308757.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal of Medicine. 2023 Sep 7;389(10):959–62.
“Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.” New England Journal of Medicine, vol. 389, no. 10, Massachusetts Medical Society, Sept. 2023, pp. 959–62. Crossref, doi:10.1056/nejmc2308757.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal of Medicine. Massachusetts Medical Society; 2023 Sep 7;389(10):959–962.
Published In
New England Journal of Medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
September 7, 2023
Volume
389
Issue
10
Start / End Page
959 / 962
Publisher
Massachusetts Medical Society
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences